A critical advance in cancer study is emerging with the use of nanobodies to re-engage damaged p53. This crucial malignant suppressor protein is frequently lost in several forms of tumors, causing uncontrolled body https://thebookpage.com/story7447649/mini-antibodies-revive-the-p53-protein-new-new-pathway-for-malignant-therapy